Suppr超能文献

凝血因子 XIII:新的结构和功能方面。

Factor XIII: novel structural and functional aspects.

机构信息

Clinical Research Center Thrombosis, Haemostasis and Vascular Biology Research Group of the Hungarian Academy of Sciences, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary.

出版信息

J Thromb Haemost. 2011 Jan;9(1):9-20. doi: 10.1111/j.1538-7836.2010.04070.x.

Abstract

Factor (F)XIII is a protransglutaminase that, in addition to maintaining hemostasis, has multiple plasmatic and intracellular functions. Its plasmatic form (pFXIII) is a tetramer of two potentially active A (FXIII-A) and two inhibitory/carrier B (FXIII-B) subunits, whereas its cellular form (cFXIII) is a dimer of FXIII-A. FXIII-A belongs to the family of transglutaminases (TGs), which show modest similarity in the primary structure, but a high degree of conservatism in their domain and sub-domain secondary structure. FXIII-A consists of an activation peptide, a β-sandwich, a catalytic and two β-barrel domains. FXIII-B is a glycoprotein consisting of 10 repetitive sushi domains each held together by two internal disulfide bonds. The structural elements of FXIII-A involved in the interaction with FXIII-B have not been elucidated; in FXIII-B the first sushi domain seems important for complex formation. In the circulation pFXIII is bound to the fibrinogen γ'-chain through its B subunit. In the process of pFXIII activation first thrombin cleaves off the activation peptide from FXIII-A, then in the presence of Ca(2+) FXIII-B dissociates and FXIII-A becomes transformed into an active transglutaminase (FXIIIa). The activation is highly accelerated by the presence of fibrin(ogen). cFXIII does not require proteolysis for intracellular activation. The three-dimensional structure of FXIIIa has not been resolved. Based on analogies with transglutaminase-2, a three-dimensional structure of FXIIIa was developed by molecular modeling, which shows good agreement with the drastic structural changes demonstrated by biochemical studies. The structural requirements for enzyme-substrate interaction and for transglutaminase activity are also reviewed.

摘要

因子(F)XIII 是一种前转谷氨酰胺酶,除了维持止血作用外,还具有多种血浆和细胞内功能。其血浆形式(pFXIII)是由两个潜在活性 A(FXIII-A)和两个抑制/载体 B(FXIII-B)亚基组成的四聚体,而其细胞形式(cFXIII)是 FXIII-A 的二聚体。FXIII-A 属于转谷氨酰胺酶(TGs)家族,它们在一级结构上具有一定的相似性,但在结构域和亚结构域的二级结构上具有高度的保守性。FXIII-A 由激活肽、β-三明治、催化和两个β-桶结构域组成。FXIII-B 是一种糖蛋白,由 10 个重复的 sushi 结构域组成,每个 sushi 结构域由两个内部二硫键连接。FXIII-A 中与 FXIII-B 相互作用的结构元素尚未阐明;在 FXIII-B 中,第一个 sushi 结构域似乎对复合物形成很重要。在循环中,pFXIII 通过其 B 亚基与纤维蛋白原γ'-链结合。在 pFXIII 激活过程中,首先凝血酶从 FXIII-A 上切下激活肽,然后在 Ca(2+)存在下,FXIII-B 解离,FXIII-A 转化为活性转谷氨酰胺酶(FXIIIa)。纤维蛋白(原)的存在极大地加速了激活过程。cFXIII 不需要蛋白水解即可在细胞内激活。FXIIIa 的三维结构尚未解析。基于与转谷氨酰胺酶-2 的类比,通过分子建模构建了 FXIIIa 的三维结构,该结构与生化研究表明的剧烈结构变化非常吻合。还综述了酶-底物相互作用和转谷氨酰胺酶活性的结构要求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验